1,080 material Form 8-K filings that 839 companies we cover made with the SEC in May 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Abercrombie & Fitch reported first quarter net sales of $1.1 billion, up 8% from a year earlier, but diluted earnings per share fell to $1.59 from $2.14 and operating margin fell to 9.3% from 12.7%. The company lowered its full-year fiscal 2025 net income per diluted share outlook to $9.50 to $10.50 from $10.40 to $11.40, and cut its operating margin outlook to 12.5% to 13.5% from 14% to 15%.
Net sales of $1.1 billion, up 8%, with comparable sales up 4%; Hollister brands up 22% and Abercrombie brands down 4%
Diluted EPS of $1.59 versus $2.14 a year earlier; operating income of $102 million versus $130 million
Full-year fiscal 2025 EPS outlook lowered to $9.50 to $10.50 from $10.40 to $11.40; net sales growth outlook of 3% to 6% versus 3% to 5% previously
Repurchased 2.6 million shares for $200 million in the quarter, with $1.1 billion remaining on the authorization set in March 2025
Kohl's reported first-quarter fiscal 2025 results for the quarter ended May 3, 2025, with net sales down 4.1% and a net loss of $15 million, compared with $27 million a year earlier. The company affirmed its full-year 2025 outlook, while the presentation says the Board reduced the annual dividend to $0.50 per share and Michael Bender is serving as Interim CEO.
Net sales decreased 4.1% to $3.0 billion; comparable sales fell 3.9%.
Net loss was $15 million, or ($0.13) per diluted share, versus $27 million, or ($0.24) per share, a year earlier.
Full-year 2025 guidance was affirmed, including diluted EPS of $0.10 to $0.60.
Quarterly dividend of $0.125 per share is payable June 25, 2025, to holders of record on June 11, 2025.
Hormel Foods reported second-quarter fiscal 2025 results for the quarter ended April 27, 2025, with net sales of $2.90 billion, up 0.4% from a year earlier, while diluted earnings per share were $0.33 compared with $0.34. The company narrowed its fiscal 2025 outlook, lowering the top of its diluted EPS range to $1.59 from $1.63 and raising the bottom of its net sales range to $12.0 billion from $11.9 billion, so shareholders face a narrower profit expectation with a lower ceiling.
Net sales of $2.90 billion, up 0.4%; organic net sales up 1%
Operating income of $248 million vs. $252 million a year earlier; adjusted operating income of $265 million vs. $276 million
Diluted EPS of $0.33 vs. $0.34; adjusted diluted EPS of $0.35 vs. $0.38
Fiscal 2025 diluted EPS range narrowed to $1.49 to $1.59 from $1.49 to $1.63; net sales range set at $12.0 to $12.2 billion from $11.9 to $12.2 billion
HP reported fiscal 2025 second-quarter net revenue of $13.2 billion, up 3.3% from a year earlier, while GAAP diluted EPS fell 31% to $0.42 and non-GAAP diluted EPS fell 13% to $0.71, below its previously provided outlook. CFO Karen Parkhill said the company adjusted its outlook for moderated demand and trade-related costs, and it now expects non-GAAP diluted EPS of $3.00 to $3.30 for fiscal 2025.
Q2 net revenue $13.2 billion, up 3.3%; GAAP diluted EPS $0.42, down from $0.61; non-GAAP diluted EPS $0.71, down from $0.82
Non-GAAP diluted EPS was below the previously provided outlook of $0.75 to $0.85; GAAP EPS was below $0.62 to $0.72
Q3 fiscal 2025 non-GAAP diluted EPS estimated at $0.68 to $0.80; full-year non-GAAP diluted EPS $3.00 to $3.30 and free cash flow $2.6 to $3.0 billion
Q2 free cash flow was $(95) million; $100 million spent on share repurchases and $273 million on dividends
StepStone Group reported fourth-quarter and full fiscal 2025 results for the period ended March 31, 2025, and declared a $0.24 quarterly dividend plus a $0.40 supplemental dividend. Revenue grew in both periods, but GAAP results weakened: the company posted a net loss attributable to StepStone of $179.6 million for the year, compared with net income of $58.1 million a year earlier. Adjusted net income per share rose, which the company highlights as a measure of core operating performance.
Full-year total revenues were $1.17 billion, up 65% from $711.6 million; full-year GAAP diluted loss per share was $2.52, versus $0.91 of income in fiscal 2024.
Fourth-quarter total revenues were $377.7 million, up from $356.8 million; net loss attributable to StepStone was $18.5 million, versus $30.8 million of net income a year earlier.
Fourth-quarter adjusted net income per share was $0.68, up from $0.33; fee-related earnings were $94.1 million, up from $50.9 million.
Dividends are payable June 30, 2025, to holders of record as of June 13, 2025.
Workday reported fiscal 2026 first-quarter revenue of $2.240 billion, up 12.6% year over year, while GAAP diluted earnings per share fell to $0.25 from $0.40 after $166 million in restructuring expenses. The company also reiterated its fiscal 2026 subscription revenue guidance of $8.8 billion, raised its non-GAAP operating margin guidance to approximately 28.5%, and authorized a new $1.0 billion share repurchase program.
Total revenues were $2.240 billion, up 12.6%; non-GAAP diluted EPS was $2.23 versus $1.74 a year earlier.
GAAP operating income was $39 million, down from $64 million, including $166 million of restructuring expenses.
Fiscal 2026 subscription revenue guidance of $8.8 billion was reiterated; non-GAAP operating margin guidance was raised to approximately 28.5%.
The Board authorized repurchases of up to $1.0 billion of Class A common stock with no expiration date.
EnerSys reported fiscal fourth-quarter 2025 net sales of $974.8 million, up 7.0%, and GAAP diluted EPS of $2.41, up 63%. Adjusted EPS of $2.97 exceeded the company's $2.75 to $2.85 guidance range. The company paused full-year quantitative guidance, citing the evolving policy environment, and gave a first-quarter fiscal 2026 outlook with lower sales and EPS ranges, while CEO David Shaffer's successor takes over May 22, 2025.
Q4 fiscal 2025 net sales $974.8 million, up 7.0%; GAAP diluted EPS $2.41 vs. $1.48 a year earlier
Adjusted diluted EPS $2.97 vs. guidance of $2.75 to $2.85 given February 5, 2025
Q1 fiscal 2026 outlook: net sales $830 million to $870 million; adjusted diluted EPS $2.03 to $2.13; full-year guidance paused
Shawn O'Connell becomes President and CEO May 22, 2025; quarterly dividend $0.24 per share payable June 27, 2025 to holders of record June 13, 2025
LiveRamp reported fourth-quarter fiscal 2025 revenue of $189 million, up 10%, and a GAAP operating loss of $12 million, narrower than $14 million a year earlier. Its fiscal 2026 guidance calls for revenue of $787 million to $817 million but a GAAP operating loss of $178 million to $182 million, compared with GAAP operating income of $5 million in fiscal 2025, so shareholders face mixed signals on growth versus profitability.
Q4 total revenue was $189 million, up 10%; GAAP operating loss was $12 million versus $14 million a year earlier.
Q4 GAAP diluted loss per share was $0.10, compared with $0.08 a year earlier.
Fiscal 2026 guidance: revenue of $787 million to $817 million, GAAP operating loss of $178 million to $182 million, and non-GAAP operating income of $85 million to $89 million.
A workforce restructuring of about 5% of full-time employees, announced March 6, drove $7.2 million of Q4 restructuring and related charges.
Brady Corporation reported fiscal 2025 third-quarter results for the period ended April 30, 2025, with sales up 11.4% to $382.6 million, helped by acquisitions, while organic sales grew 1.6%. The company narrowed its full-year adjusted diluted EPS guidance to $4.48 to $4.63 from $4.45 to $4.70, and lowered its GAAP EPS guidance to $3.95 to $4.10 from $3.99 to $4.24, so shareholders get a record adjusted quarter alongside a lower GAAP outlook.
Q3 diluted EPS rose 3.8% to $1.09; adjusted diluted EPS rose 11.9% to a record $1.22
Sales of $382.6 million included 10.5% growth from acquisitions and 1.6% organic growth; Europe & Australia organic sales fell 5.4%
Full-year adjusted EPS guidance tightened to $4.48 to $4.63; GAAP EPS guidance lowered to $3.95 to $4.10
Returned $44.5 million to shareholders in the quarter through dividends and share repurchases
Take-Two Interactive reported fourth-quarter fiscal 2025 GAAP net revenue up 13% to $1.58 billion, but a GAAP net loss of $3.73 billion, or $21.08 per share, driven by a $3.55 billion goodwill impairment. For the full fiscal year, net revenue rose 5% to $5.63 billion while the net loss widened to $4.48 billion. The initial fiscal 2026 Net Bookings outlook is $5.9 to $6.0 billion, and the company expects a GAAP net loss per share of $(2.79) to $(2.45).
Q4 net revenue rose 13% to $1.58 billion from $1.40 billion; Net Bookings grew 17% to $1.58 billion
Q4 GAAP net loss was $3.73 billion ($21.08 per share), versus $2.90 billion ($17.02 per share) a year earlier
Full-year GAAP net loss was $4.48 billion ($25.58 per share), versus $3.74 billion ($22.01 per share); goodwill impairment was $3.55 billion
Fiscal 2026 outlook: Net Bookings of $5.9 to $6.0 billion and GAAP total net revenue of $5,950 to $6,050 million
Acadia Healthcare reported first-quarter 2025 revenue of $770.5 million, up slightly from $768.1 million a year earlier, but net income attributable to the company fell to $8.4 million, or $0.09 per diluted share, from $76.4 million, or $0.83. The company affirmed its full-year 2025 guidance, which includes $2.50 to $2.80 in adjusted earnings per diluted share.
Revenue was $770.5 million versus $768.1 million in Q1 2024, a 0.3% increase.
Net income attributable to Acadia was $8.4 million ($0.09 per diluted share), down from $76.4 million ($0.83) a year earlier.
Adjusted EBITDA was $134.2 million versus $173.9 million, and transaction, legal and other costs were $31.1 million, including $31.0 million of government investigation costs.
Full-year 2025 guidance was affirmed, including revenue of $3.3 to $3.4 billion and adjusted EBITDA of $675 to $725 million.
Topgolf Callaway Brands reported first-quarter 2025 net revenues of $1,092.3 million, down 4.5% from a year earlier, and GAAP net income of $2.1 million, or $0.01 per diluted share, versus $6.5 million a year earlier. The company kept its full-year consolidated revenue and Adjusted EBITDA guidance but lowered its Topgolf revenue outlook because of a softer consumer environment, and the guidance remains subject to the pending sale of Jack Wolfskin.
Q1 2025 net revenues were $1,092.3 million, down 4.5%; GAAP net income was $2.1 million, or $0.01 per diluted share, versus $0.04 a year earlier.
Non-GAAP diluted EPS was $0.11 versus $0.08, and Adjusted EBITDA rose 4.0% to $167.3 million.
Full-year consolidated net revenue ($4.000 billion to $4.185 billion) and Adjusted EBITDA ($415 million to $505 million) guidance was maintained, while Topgolf revenue guidance was lowered to $1.680 billion to $1.790 billion from $1.725 bil
Q2 2025 outlook calls for consolidated net revenues of $1.075 billion to $1.115 billion and Adjusted EBITDA of $139 million to $159 million.
ZoomInfo reported first quarter 2025 GAAP revenue of $305.7 million, down 1% from a year earlier, while GAAP operating income rose to $50.3 million from $43.0 million and diluted EPS was $0.08 versus $0.04. The company raised the low end of its full-year 2025 GAAP revenue guidance to $1.195 billion-$1.205 billion from $1.185 billion-$1.205 billion, and its adjusted EPS guidance to $0.96-$0.98 from $0.95-$0.97. Shareholders also learn that the stock will begin trading under the symbol GTM on May 13, 2025.
GAAP revenue of $305.7 million, down 1% year over year; adjusted operating income of $100.9 million, down 15%
GAAP net income of $26.8 million, or $0.08 per diluted share, versus $15.1 million, or $0.04, a year earlier
Full-year 2025 GAAP revenue guidance of $1.195 billion-$1.205 billion, with the prior range at $1.185 billion-$1.205 billion
Common stock to trade on Nasdaq as GTM before market open on May 13, 2025, replacing the ZI symbol
RadNet reported first-quarter 2025 revenue of $471.4 million, up 9.2%, but Adjusted EBITDA fell 20.6% to $46.4 million and the company posted a net loss attributable to RadNet of $37.9 million, compared with a $2.8 million loss a year earlier. The company raised its full-year 2025 revenue and Adjusted EBITDA guidance ranges, citing the Southern California wildfires and severe winter weather that it said reduced first-quarter revenue by about $22 million.
Total Company revenue rose to $471.4 million from $431.7 million; Adjusted EBITDA fell to $46.4 million from $58.5 million.
Net loss per share was $(0.51) versus $(0.04) a year earlier; adjusted diluted loss per share was $(0.35) versus adjusted earnings of $0.07.
Imaging Center revenue guidance was raised to $1,835 million to $1,885 million from $1,825 million to $1,875 million; Adjusted EBITDA guidance was raised to $268 million to $276 million from $265 million to $273 million.
RadNet signed a definitive agreement on April 15, 2025 to acquire iCAD, Inc., subject to customary closing conditions.
Fortrea reported first-quarter 2025 revenue of $651.3 million, down from $662.1 million a year earlier, and a GAAP net loss of $562.9 million that includes a non-cash goodwill impairment charge of $488.8 million. Adjusted EBITDA rose to $30.3 million from $27.1 million, and the company reiterated its full-year 2025 guidance. Chairman and CEO Thomas Pike will step down on May 13, 2025, and Lead Independent Director Peter M. Neupert will serve as interim CEO and Board Chair.
Revenue was $651.3 million in the quarter, compared with $662.1 million in the first quarter of 2024.
GAAP net loss was $562.9 million, or $6.25 per diluted share, including the $488.8 million goodwill impairment; adjusted EPS was $0.02 versus $(0.05) a year earlier.
Adjusted EBITDA was $30.3 million, compared with $27.1 million in the first quarter of 2024.
Full-year 2025 guidance was reiterated at revenue of $2.45 billion to $2.55 billion and adjusted EBITDA of $170 million to $200 million; Peter M. Neupert becomes interim CEO on May 13, 2025.
Sally Beauty reported fiscal second-quarter results for the period ended March 31, 2025, with net sales down 2.8% to $883.1 million and comparable sales down 1.3%. GAAP diluted EPS rose to $0.38 from $0.27, and adjusted diluted EPS rose 20% to $0.42, while the company updated its full-year fiscal 2025 guidance and extended its share repurchase program to September 30, 2029.
Net sales of $883.1 million, down 2.8%; comparable sales down 1.3%, which the company attributed to weather, an unusually harsh flu season and macro uncertainty
GAAP diluted EPS of $0.38 versus $0.27 a year earlier; adjusted diluted EPS of $0.42 versus $0.35, a 20% increase
Full-year fiscal 2025 guidance: comparable sales flat to down 1%; adjusted operating margin of 8.0% to 8.5%
Board approved extending the share repurchase program to September 30, 2029, with $501.1 million remaining under the authorization
Koppers reported first-quarter 2025 sales of $456.5 million, down from $497.6 million, and a net loss attributable to Koppers of $13.9 million, compared with net income of $13.0 million a year earlier. The results include a $29.0 million loss on pension settlement and $20.0 million of impairment, restructuring and plant closure costs. The company lowered its 2025 sales forecast to $2.0 billion to $2.2 billion from $2.17 billion but kept its adjusted EBITDA goal of approximately $280 million and adjusted EPS goal of $4.75.
Adjusted EPS was $0.71 versus $0.62 a year earlier, while diluted EPS was $(0.68) versus $0.59
2025 sales forecast cut to $2.0 billion to $2.2 billion from $2.17 billion; adjusted EBITDA and adjusted EPS goals maintained
At the May 8, 2025 annual meeting, shareholders approved the amended 2020 Long Term Incentive Plan with 12,093,826 votes for and 5,231,663 against
Post Holdings reported fiscal second-quarter 2025 results for the period ended March 31, 2025. Net sales fell 2.3% to $1,952.1 million and diluted earnings per share fell to $1.03 from $1.48, while Adjusted EBITDA rose 0.4% to $346.5 million. The company raised its fiscal 2025 Adjusted EBITDA guidance to $1,430-$1,470 million, so shareholders get weaker reported sales and profit alongside a higher profit outlook.
Q2 net sales were $1,952.1 million, down 2.3% from $1,999.0 million a year earlier
Net earnings were $62.6 million, down 35.6%; diluted EPS was $1.03 versus $1.48
Adjusted EBITDA was $346.5 million, up 0.4% from $345.2 million
Fiscal 2025 Adjusted EBITDA guidance raised to $1,430-$1,470 million from $1,420-$1,460 million
Globus Medical reported first-quarter 2025 net sales of $598.1 million, down 1.4% from a year earlier, while GAAP net income rose to $75.5 million from a loss of $7.1 million. The company cut its full-year 2025 non-GAAP diluted EPS guidance to $3.00 to $3.30 from $3.10 to $3.40, but reaffirmed its full-year revenue guidance of $2.80 to $2.90 billion. Shareholders get a mixed picture: profit improved, but sales declined and the earnings outlook was lowered.
Net sales were $598.1 million, down 1.4% (down 0.8% on a constant currency basis); U.S. sales rose 0.2% while international sales fell 7.7%.
GAAP diluted EPS was $0.54, compared with a loss of $0.05 a year earlier; non-GAAP diluted EPS was $0.68, up from $0.63.
Full-year 2025 non-GAAP diluted EPS guidance was lowered to $3.00 to $3.30 from $3.10 to $3.40; revenue guidance of $2.80 to $2.90 billion was reaffirmed.
The company paid off the remaining $450 million of debt assumed from the NuVasive merger and reported free cash flow of $141.2 million.
Coinbase reported first-quarter 2025 total revenue of $2.0 billion, down 10% from the prior quarter, and net income of $66 million, with results weighed down by $597 million in pre-tax losses on its crypto investment portfolio. The letter also announced an agreement to acquire Deribit for approximately $2.9 billion, paid in $700 million cash and 11 million shares, which shareholders should weigh against the lower quarterly profit.
Q1 total revenue was $2.0 billion, down 10% from Q4 2024; transaction revenue was $1.3 billion, down 19%
Net income was $66 million, compared with $1.29 billion in Q4 2024; Adjusted EBITDA was $930 million
Subscription and services revenue rose 9% to $698 million, driven mainly by stablecoin revenue
Agreement to acquire Sentillia B.V. (Deribit) for about $2.9 billion, expected to close by year-end, subject to regulatory approvals
HubSpot reported first-quarter 2025 revenue of $714.1 million, up 16% from a year earlier, while its GAAP net result swung to a $21.8 million loss from $5.9 million of net income. The company also issued revenue and non-GAAP profit guidance for the second quarter and full year, and its board authorized a $500.0 million share repurchase program.
Q1 2025 total revenue $714.1 million, up 16% as reported; GAAP net loss $21.8 million ($0.42 per share) versus net income of $5.9 million ($0.12 per share) in Q1 2024
Non-GAAP diluted net income per share $1.78, compared with $1.68 in Q1 2024
Guidance: Q2 2025 revenue $738.0 million to $740.0 million; full-year 2025 revenue $3.036 billion to $3.044 billion and non-GAAP diluted EPS $9.29 to $9.37
Board authorized up to $500.0 million in share repurchases on May 6, 2025 over up to 12 months; Brian Halligan resigned as Executive Chairperson effective May 8, 2025 and Lorrie Harrington became Chairperson
Solventum reported first-quarter 2025 sales up 2.6% to $2.1 billion, with organic sales up 4.3%. Profit fell sharply: net income was $137 million versus $237 million a year earlier, and GAAP diluted EPS was $0.78 versus $1.37. The company raised its full-year 2025 organic sales growth outlook to +1.5% to +2.5% but left its adjusted EPS and free cash flow guidance unchanged.
Net sales rose 2.6% to $2.1 billion; organic sales rose 4.3% for the quarter.
GAAP diluted EPS was $0.78 versus $1.37; adjusted diluted EPS was $1.34 versus $2.08.
Free cash flow was negative $80 million versus $340 million a year earlier.
Full-year organic sales growth outlook raised to +1.5% to +2.5% from +1.0% to +2.0%; adjusted EPS guidance of $5.45 to $5.65 unchanged.
Fox Factory reported first-quarter fiscal 2025 net sales of $355 million, up 6.5% from a year earlier, but a $262.1 million goodwill impairment drove a net loss attributable to stockholders of $259.7 million, or $6.23 per diluted share. Adjusted earnings per diluted share fell to $0.23 from $0.29, and the company reaffirmed its full-year 2025 guidance while giving a second-quarter outlook.
Net sales rose $22 million, or 6.5%, to $355.0 million; the company cited tariff-related uncertainty and challenging end-market demand.
The goodwill impairment followed adverse U.S. tariff policy changes and a sustained decline in the stock price; goodwill fell to $377.2 million from $639.5 million.
Second-quarter guidance calls for net sales of $340 million to $360 million and adjusted earnings per diluted share of $0.32 to $0.62.
For fiscal 2025, the company reaffirmed net sales of $1.385 billion to $1.485 billion and adjusted earnings per diluted share of $1.60 to $2.60.
ScanSource reported fiscal third-quarter 2025 net sales of $704.8 million, down 6.3% year over year, while GAAP diluted EPS rose to $0.74 from $0.50. The company replaced its fiscal 2025 outlook, now expecting net sales of approximately $3 billion and adjusted EBITDA of $140 million to $145 million, and announced a new $200 million share repurchase authorization.
Q3 net sales were $704.8 million, down 6.3%; GAAP net income was $17.4 million, or $0.74 per diluted share, versus $0.50 a year earlier
Non-GAAP diluted EPS was $0.86, up 24.6%; adjusted EBITDA rose 5.9% to $35.1 million
FY25 outlook: net sales of approximately $3 billion (prior $3.1 billion to $3.5 billion); adjusted EBITDA of $140 million to $145 million (prior $140 million to $160 million); free cash flow at least $70 million, unchanged
Board approved a new $200 million buyback; about $42 million remained under the existing authorization as of March 31, 2025
Choice Hotels reported first-quarter 2025 net income of $44.5 million, up 44% from a year earlier, with diluted EPS of $0.94 versus $0.62. The company also lowered its full-year 2025 outlook, including net income guidance of $275 million to $290 million, down from $288 million to $300 million, and domestic RevPAR growth of -1% to 1%, down from 1% to 2%.
Q1 2025 total revenues were $333 million, compared with $332 million in Q1 2024.
Adjusted diluted EPS was $1.34, up 5% from $1.28, which the company called a first-quarter record.
Full-year 2025 adjusted diluted EPS guidance is $6.90 to $7.22, down from $6.98 to $7.24.
Management cited a more moderate domestic RevPAR growth expectation amid a changing macro backdrop.
Vericel reported first-quarter 2025 total revenue of $52.6 million, up from $51.3 million a year earlier, but its net loss widened to $11.2 million, or $0.23 per diluted share, from $3.9 million, or $0.08 per share. The company raised its full-year profitability guidance to a 74% gross margin and 26% adjusted EBITDA margin while reaffirming full-year revenue growth of 20% to 23%.
Q1 2025 total revenue of $52.6 million versus $51.3 million in Q1 2024; MACI net revenue of $46.3 million
Net loss of $11.2 million, or $0.23 per diluted share, versus a net loss of $3.9 million, or $0.08 per share, a year earlier
Full-year profitability guidance raised to 74% gross margin and 26% adjusted EBITDA margin
Second-quarter total revenue growth expected to be 22% to 25%; full-year revenue growth guidance of 20% to 23% reaffirmed
Viatris reported first quarter 2025 total revenues of $3.3 billion, down 11% from a year earlier, and a U.S. GAAP net loss of $3.0 billion, driven by a non-cash goodwill impairment charge of $2.9 billion. Adjusted EPS was $0.50, down 25%, and the company reaffirmed its 2025 outlook, including adjusted EPS guidance of $2.16 to $2.30. The filing also says the company has returned more than $450 million to shareholders year to date.
Total revenues $3.3 billion (down 11% reported; down 2% divestiture-adjusted operational basis); Indore Impact estimated at approximately $140 million in the quarter
U.S. GAAP net loss $(3.0) billion, or $(2.55) per share, versus net earnings of $114 million, or $0.09 per share, a year earlier
Adjusted EPS $0.50 versus $0.67 a year earlier; adjusted EBITDA $923.5 million, down 23%
2025 guidance reaffirmed; share repurchases of $500 million to $650 million expected in 2025
NetScout reported fourth-quarter fiscal 2025 revenue of $205.0 million, up from $203.4 million a year earlier, and GAAP net income of $18.6 million. For the full year, revenue fell to $822.7 million from $829.5 million, and the company posted a GAAP net loss of $366.9 million that includes $427.0 million in goodwill charges. Its CFO and COO are retiring effective May 31, 2025, with named successors starting June 1, 2025.
Q4 fiscal 2025 revenue was $205.0 million versus $203.4 million a year earlier; GAAP net income was $18.6 million, or $0.25 per diluted share, compared with a net loss of $32.4 million.
Fiscal 2025 revenue was $822.7 million versus $829.5 million; GAAP net loss was $366.9 million, or $(5.12) per diluted share, including goodwill charges of $427.0 million.
Fiscal 2026 outlook calls for revenue of $825 million to $865 million and GAAP diluted EPS of $1.07 to $1.22.
CFO Jean Bua and COO Michael Szabados step down effective May 31, 2025; Anthony Piazza becomes CFO and Sanjay Munshi becomes COO effective June 1, 2025.
Dave Inc. reported first quarter 2025 results on May 8, 2025, with revenue up 47% to $108.0 million and Adjusted EBITDA up 235% to $44.2 million. GAAP net income fell to $28.8 million from $34.2 million, a year-earlier period that included a $33.4 million gain on extinguishment of convertible debt. The company raised its full-year 2025 revenue and Adjusted EBITDA guidance and authorized a $50 million share repurchase program.
Q1 2025 GAAP operating revenues of $108.0 million, up from $73.6 million in Q1 2024
GAAP net income of $28.8 million, down from $34.2 million; the prior-year period included a $33.4 million gain on extinguishment of convertible debt
Adjusted EBITDA of $44.2 million, up 235% from $13.2 million a year earlier
2025 revenue guidance raised to $460-$475 million from $415-$435 million; Adjusted EBITDA guidance raised to $155-$165 million from $110-$120 million
N-able reported first-quarter 2025 revenue of $118.2 million, up 3.9% year over year, and beat the high end of its first-quarter revenue and adjusted EBITDA guidance. It raised the midpoint of its full-year 2025 revenue outlook to $494.5 million from $489.5 million, but swung to a GAAP net loss of $7.2 million, or $(0.04) per diluted share, from net income of $7.5 million a year earlier.
Q1 2025 total revenue $118.2 million, up 3.9% year over year; GAAP net loss $7.2 million versus net income of $7.5 million in Q1 2024
Adjusted EBITDA $31.6 million, a 26.8% margin; non-GAAP net income $15.6 million, or $0.08 per diluted share
Full-year 2025 revenue midpoint raised to $494.5 million from $489.5 million; range $492 million to $497 million
Board approved a share repurchase program of up to $75 million of common stock
Valvoline reported fiscal second-quarter sales of $403 million, up 4%, while reported earnings per diluted share fell 9% to $0.30 and income from continuing operations fell 12% to $38 million. The company reiterated its fiscal 2025 guidance and said it named J. Kevin Willis as Chief Financial Officer, effective May 19, 2025, which shareholders may watch as the finance leadership changes.
Net revenues of $403.2 million rose 4% (11% excluding the impact of refranchising); reported EPS of $0.30 fell 9%
Adjusted EPS of $0.34 decreased 8%; adjusted EBITDA of $104 million declined 1%
Company reiterated fiscal 2025 guidance, including a target of 160 to 185 new store additions
J. Kevin Willis to become CFO effective May 19, 2025, with a base salary of $650,000; he succeeds Mary Meixelsperger, who is retiring
Peloton reported fiscal third-quarter 2025 results for the quarter ended March 31, 2025. Total revenue fell 13% year-over-year to $624.0 million, while the GAAP net loss narrowed to $47.7 million from $167.3 million a year earlier and Adjusted EBITDA rose to $89.4 million. The company raised its full-year FY25 Adjusted EBITDA guidance to $330 million to $350 million and its Total Revenue guidance to $2.455 billion to $2.470 billion.
Total revenue was $624.0 million, down 13% year-over-year, with Connected Fitness Products Revenue down 27% to $205.5 million.
GAAP net loss was $47.7 million, compared with $167.3 million in the same quarter last year.
Adjusted EBITDA was $89.4 million, and the company reported $94.7 million of Free Cash Flow in the quarter.
FY25 guidance: Adjusted EBITDA raised to $330 million to $350 million; Total Revenue raised to $2.455 billion to $2.470 billion; Total Gross Margin held at 50.0%.
Somnigroup reported first quarter 2025 net sales of $1,604.7 million, up 34.9%, driven largely by the February 5, 2025 Mattress Firm acquisition. The company swung to a net loss of $33.1 million, or $0.17 per diluted share, from net income of $76.3 million, or $0.43 per share, a year earlier, and revised its full-year 2025 adjusted EPS expectations to a range of $2.30 to $2.65.
Q1 net sales rose 34.9% to $1,604.7 million, including $593.7 million from Mattress Firm for the February 5 to March 31 stub period.
Net loss was $33.1 million (loss of $0.17 per diluted share) versus net income of $76.3 million ($0.43 per share) in Q1 2024; operating income fell to $13.2 million from $131.5 million.
Adjusted EPS was $0.49 versus $0.50 a year earlier; the company revised its full-year 2025 adjusted EPS range to $2.30 to $2.65.
Board declared a quarterly cash dividend of $0.15 per share, payable June 5, 2025, to holders of record on May 22, 2025.
Lincoln National reported a first-quarter 2025 net loss available to common stockholders of $756 million, or $4.41 per diluted share, compared with net income of $1,191 million a year earlier. The company said the loss mainly reflected changes in market risk benefits from lower interest rates and equity markets, while adjusted operating income rose to $280 million, or $1.60 per diluted share, from $210 million, or $1.22.
Net loss available to common stockholders was $756 million, or $4.41 per diluted share, versus net income of $1,191 million, or $6.93 per diluted share, in Q1 2024.
Adjusted operating income available to common stockholders was $280 million, or $1.60 per diluted share, up from $210 million, or $1.22.
Group Protection operating income rose 26% to $101 million, with an operating margin of 7.4%.
A minority investment from Bain Capital is expected to close in the second half of 2025.
Haemonetics reported fourth-quarter fiscal 2025 revenue of $330.6 million, down 3.7% from a year earlier, while GAAP earnings per diluted share rose to $1.17 from $0.40 and adjusted EPS rose 37.8% to $1.24. The company also issued fiscal 2026 guidance, including adjusted EPS of $4.70 to $5.00, and approved a market and regional alignment initiative expected to bring about $20 million in restructuring charges and about $30 million in annualized savings.
Q4 fiscal 2025 revenue $330.6 million, down 3.7%; organic revenue down 0.2%, with Plasma down 9.1% and Blood Center down 22.2%
Q4 GAAP EPS $1.17 vs $0.40; adjusted EPS $1.24, up 37.8%
Fiscal 2026 guidance: adjusted EPS $4.70 to $5.00, adjusted operating margin 26% to 27%, free cash flow $160 million to $200 million
Alignment initiative: about $20 million in charges, mostly cash, through fiscal 2027; about $30 million annualized savings once complete
EPAM reported first-quarter 2025 revenue of $1.302 billion, up 11.7% from a year earlier, but GAAP diluted EPS fell 35.0% to $1.28 and non-GAAP diluted EPS fell 2.0% to $2.41. The company raised its full-year 2025 revenue growth outlook to 11.5% to 14.5%, and CEO Arkadiy Dobkin will become Executive Chairman on September 1, 2025, with Balazs Fejes succeeding him as CEO and President. Organic constant currency revenue growth was 1.4% in the quarter, so most of the reported growth came from acquisitions and currency effects.
Q1 2025 revenue was $1.302 billion, up 11.7%; organic constant currency growth was 1.4%
Q1 GAAP diluted EPS was $1.28, down 35.0%; non-GAAP diluted EPS was $2.41, down 2.0%
Full-year 2025 revenue growth outlook raised to 11.5% to 14.5%; GAAP diluted EPS outlook is $6.78 to $7.03
Balazs Fejes becomes CEO and President effective September 1, 2025, succeeding Arkadiy Dobkin, who becomes Executive Chairman
Kinetik Holdings reported first quarter 2025 results, with total operating revenues of $443.3 million, up from $341.4 million a year earlier, and Adjusted EBITDA of $250.0 million, up from $233.6 million. Net income fell to $19.3 million from $35.4 million, and diluted earnings per share were $0.05 versus $0.12, while the company affirmed its 2025 Adjusted EBITDA guidance of $1.09 billion to $1.15 billion and raised its share repurchase authorization to $500 million.
Total operating revenues were $443.3 million, compared with $341.4 million in the first quarter of 2024.
Net income including noncontrolling interest was $19.3 million, versus $35.4 million; diluted EPS was $0.05, versus $0.12.
Adjusted EBITDA was $250.0 million, versus $233.6 million; the company said current commodity futures would reduce full-year Adjusted EBITDA by about $20 million.
The Board authorized an increase to the share repurchase program to $500 million and affirmed 2025 Adjusted EBITDA guidance of $1.09 billion to $1.15 billion.
Goodyear reported first quarter 2025 net sales of $4.3 billion, down from $4.5 billion a year earlier, and net income of $115 million (40 cents per share), helped by a $260 million estimated gain on the sale of its Off-the-Road tire business. Excluding significant items, the company posted an adjusted net loss of $11 million (a loss of 4 cents per share), compared with adjusted net income of $29 million a year earlier. On May 7, 2025, it also completed the sale of the Dunlop brand rights to Sumitomo Rubber Industries for $735 million in gross cash proceeds, which Goodyear says it intends to use to reduce leverage.
Q1 2025 net sales were $4.3 billion, compared with $4.5 billion in Q1 2024; GAAP net income was $115 million (40 cents per share) versus a net loss of $57 million (20 cents per share) a year earlier.
Adjusted net loss was $11 million (a loss of $0.04 per share), compared with adjusted net income of $29 million ($0.10 per share) in the prior year quarter.
Segment operating income was $195 million, down $52 million from a year ago, driven by higher raw material costs, with Goodyear Forward benefits of $200 million.
The Dunlop brand sale to Sumitomo Rubber Industries closed May 7, 2025, with gross cash proceeds of $735 million, including $526 million for the brand.
Tetra Tech reported second-quarter fiscal 2025 revenue of $1.322 billion, up 6% year over year, and adjusted EPS of $0.33, up 18%, and raised its full-year net revenue and adjusted EPS guidance. GAAP EPS fell to $0.02 from $0.28 after a $92.4 million non-cash goodwill impairment tied to terminated USAID contracts. The company also entered a $1.5 billion credit agreement maturing in 2030 and declared a $0.065 quarterly dividend, up 12%.
Q2 revenue $1.322 billion (up 6%); net revenue $1.104 billion (up 5%); reported operating income $39.6 million vs. $117.7 million a year earlier
FY25 net revenue guidance raised to $4.400 billion to $4.765 billion; adjusted EPS guidance raised to $1.42 to $1.52
Credit agreement dated May 5, 2025: $250 million 5-year term loan, $600 million revolver, $250 million 3-year term loan; matures 2030 (5-year) and May 5, 2028 (3-year)
Quarterly dividend of $0.065 per share payable June 5, 2025 to holders of record May 23, 2025; additional $500 million buyback approved, leaving $673 million available
Axon reported first-quarter 2025 revenue of $604 million, up 31% year over year, and raised its full-year 2025 revenue outlook to $2.60 billion to $2.70 billion. The company also said on May 1, 2025, its Audit Committee concluded that its 2024 annual financial statements and the 2024 quarterly statements for March 31 and September 30 should no longer be relied upon, because $690.0 million of convertible notes were presented as long-term rather than current liabilities. Total assets, total liabilities and stockholders' equity were not affected, but the filing discloses an additional material weakness in internal control over financial reporting.
Q1 2025 revenue of $604 million, up 31% year over year; net income of $88 million, or $1.08 per diluted share
Full-year 2025 revenue outlook raised to $2.60 billion to $2.70 billion, from $2.55 billion to $2.65 billion
Audit Committee concluded on May 1, 2025 that 2024 annual and 2024 Q1 and Q3 financial statements should no longer be relied upon
The $690.0 million 2027 convertible notes are reclassified from long-term to current liabilities; an additional material weakness in internal controls was identified
Concentra reported first-quarter 2025 revenue up 7.1% to $500.8 million and raised its full-year 2025 revenue and Adjusted EBITDA guidance. Net income fell 19.2% to $40.6 million, and earnings per share were $0.30 versus $0.47, which the company attributed to higher interest expense from its IPO recapitalization. The Board also declared a $0.0625 per share cash dividend.
Q1 2025 revenue was $500.8 million, up from $467.6 million; net income was $40.6 million, down from $50.3 million
Earnings per share were $0.30 versus $0.47 a year earlier; adjusted EPS was $0.32 versus $0.49
2025 guidance now calls for revenue of $2.1 billion to $2.15 billion and Adjusted EBITDA of $415 million to $430 million
Dividend of $0.0625 per share is payable May 29, 2025, to holders of record on May 20, 2025; the $55 million Pivot Onsite Innovations acquisition is expected to close in Q2 2025
Helmerich & Payne reported fiscal second-quarter 2025 results for the quarter ended March 31, 2025, after completing its KCA Deutag acquisition on January 16, 2025. Operating revenues rose to $1.0 billion from $687.9 million a year earlier, but net income attributable to the company fell to $1.7 million, or $0.01 per diluted share, from $84.8 million, or $0.84 per diluted share. The company also expects third-quarter direct margin in each segment to be lower than the strong North America Solutions result, and it now targets $50 to $75 million in overall cost reductions.
Operating revenues were $1,016.0 million, compared with $687.9 million a year earlier and $677.3 million in the prior quarter.
Net income attributable to Helmerich & Payne was $1.7 million ($0.01 per diluted share), versus $84.8 million ($0.84 per diluted share) a year earlier; transaction and integration costs were $29.9 million.
Management expects overall cost structure reductions of $50 to $75 million, with the full impact recognized in fiscal 2026.
Third-quarter guidance includes North America Solutions direct margin of $235 million to $260 million and International Solutions direct margin of $25 million to $35 million.
Crane NXT reported first quarter 2025 sales of $330.3 million, up 5.3% from a year earlier, but GAAP earnings per diluted share fell to $0.38 from $0.66 as operating profit dropped to $37.3 million from $55.4 million. The company raised its full year 2025 sales growth guidance to 6% to 8% and kept its adjusted EPS guidance at $4.00 to $4.30, after completing the De La Rue Authentication acquisition on May 1, 2025.
Q1 2025 sales were $330.3 million, up 5.3%, with acquisitions adding $33.4 million and core sales down 4.1%.
GAAP EPS was $0.38 versus $0.66 a year earlier; adjusted EPS was $0.54 versus $0.85.
Full year 2025 sales growth guidance was raised to 6% to 8% from 1% to 3%; adjusted EPS guidance of $4.00 to $4.30 was unchanged.
The company completed the De La Rue Authentication acquisition on May 1, 2025 for £300 million in cash and declared a $0.17 quarterly dividend payable June 11, 2025.
Innoviva reported first-quarter 2025 total revenue of $88.6 million, up from $77.5 million a year earlier, and income from operations rose 61% to $41.4 million. Unfavorable fair value changes in equity and long-term investments of $78.8 million produced a net loss of $46.6 million, or $0.74 per basic share, compared with net income of $36.5 million, or $0.58 per share, in the first quarter of 2024. The results are mixed for shareholders: operating performance improved, but investment valuation losses turned the bottom line negative.
Total revenue was $88.6 million versus $77.5 million; income from operations was $41.4 million, up from $25.8 million.
U.S. net product sales were $26.4 million, a 52% increase year over year, led by $17.4 million from GIAPREZA.
Net loss was $46.6 million, or $0.74 per basic share, versus net income of $36.5 million, or $0.58 per share.
Gross royalty revenue from GSK was $61.3 million, compared with $61.9 million; cash and cash equivalents were $319.1 million at March 31, 2025.
Paycom reported first-quarter 2025 revenue of $530.5 million, up 6.1% from a year earlier, and non-GAAP net income of $157.7 million, or $2.80 per diluted share. GAAP net income fell to $139.4 million, or $2.48 per diluted share, from $247.2 million a year earlier, when results included a $117.5 million benefit from a forfeited CEO performance award. Chief executive Chad Richison said the company is raising its outlook for 2025.
Q1 2025 total revenues were $530.5 million, up 6.1% from $499.9 million.
GAAP net income was $139.4 million, or $2.48 per diluted share, versus $247.2 million, or $4.37, in Q1 2024, which included a $117.5 million benefit.
Non-GAAP net income was $157.7 million, or $2.80 per diluted share, versus $146.6 million, or $2.59, a year earlier.
2025 guidance: total revenue of $2.023 billion to $2.038 billion and adjusted EBITDA of $843.0 million to $858.0 million.
Digi International reported fiscal second-quarter 2025 results for the period ended March 31, 2025. Revenue fell 3% to $105 million, while net income rose to $10 million from $4 million and diluted EPS rose to $0.28 from $0.11. The company raised its fiscal 2025 profit outlook, now projecting Adjusted EBITDA growth of 5%, but its revenue outlook of roughly flat year over year is unchanged.
Revenue was $105 million, down 3% year over year; ARR reached $123 million, up 12%.
Net income was $10 million ($0.28 per diluted share) versus $4 million ($0.11) a year earlier; adjusted EPS was $0.51 versus $0.49.
Fiscal 2025 Adjusted EBITDA is now projected to grow 5% year over year, up from a prior projection of roughly flat.
Debt was reduced to $70.0 million at quarter end; the company expects a net cash positive position at fiscal year end.
Genpact reported first-quarter 2025 net revenues of $1.215 billion, up 7.4% year-over-year, and adjusted diluted EPS of $0.84, up 16%. The company cut its full-year 2025 revenue growth outlook to 2.0% to 5.0% from 5.5% to 7.5%, and lowered its adjusted diluted EPS range to $3.41 to $3.52 from $3.52 to $3.59, which matters to shareholders because the earnings forecast came down even as quarterly results grew.
Q1 2025 net income was $131 million, up 12%, and diluted EPS was $0.73, up 14%.
Full-year 2025 net revenue guidance is $4.862 billion to $5.005 billion, down from the prior growth range of 5.5% to 7.5%.
Full-year 2025 adjusted diluted EPS guidance is $3.41 to $3.52, down from $3.52 to $3.59.
Genpact repurchased about 1.2 million shares for approximately $63 million during the quarter.
CoreCivic reported first-quarter 2025 net income of $25.1 million, or $0.23 per diluted share, up from $9.5 million, or $0.08, a year earlier, while revenue fell to $488.6 million from $500.7 million. The prior-year quarter included $27.2 million of debt refinancing expenses, and on an adjusted basis diluted EPS was $0.25 a year earlier, so adjusted EPS declined. The company raised its full-year 2025 net income guidance to $91.3 million to $101.3 million, reflecting reactivation of idle facilities under ICE agreements.
Q1 2025 revenue was $488.6 million, versus $500.7 million in Q1 2024; ICE revenue was $133.2 million, versus $153.8 million.
Q1 2025 net income was $25.1 million ($0.23 diluted EPS), versus $9.5 million ($0.08) in Q1 2024; Q1 2024 adjusted diluted EPS was $0.25.
Full-year 2025 net income guidance was raised to $91.3 million to $101.3 million from $53.5 million to $67.5 million; diluted EPS guidance rose to $0.83 to $0.92 from $0.48 to $0.61.
In Q1 2025 the company repurchased 1.9 million shares for $37.9 million, leaving $131.0 million of authorization as of March 31, 2025.
Lantheus reported first-quarter 2025 revenue of $372.8 million, up 0.8% from a year earlier, while GAAP diluted earnings per share fell to $1.02 from $1.87 and adjusted diluted EPS fell 9.5% to $1.53. The company lowered its full-year 2025 adjusted diluted EPS guidance to $6.60-$6.70 from $7.00-$7.20, which means lower expected profit for shareholders even as revenue guidance was narrowed.
Q1 2025 GAAP diluted EPS was $1.02, down from $1.87; adjusted diluted EPS was $1.53, down 9.5% from $1.69.
FY2025 adjusted diluted EPS guidance cut to $6.60-$6.70, from $7.00-$7.20 issued February 26, 2025.
FY2025 revenue guidance narrowed to $1.550-$1.585 billion, from $1.545-$1.610 billion.
Agreed to sell the SPECT business to SHINE; the transaction is expected to close by the end of 2025.
Charles River Laboratories reported first-quarter 2025 revenue of $984.2 million, down 2.7% from $1,011.6 million a year earlier, with GAAP diluted earnings per share of $0.50 versus $1.30. Non-GAAP diluted EPS rose 3.1% to $2.34, and the company raised its 2025 non-GAAP EPS guidance to $9.30 to $9.80 from $9.10 to $9.60, which matters to shareholders because revenue and GAAP profit declined while the outlook moved higher.
Q1 2025 revenue was $984.2 million, down 2.7% from $1,011.6 million; organic revenue fell 1.8%.
GAAP diluted EPS was $0.50 versus $1.30 in Q1 2024; non-GAAP diluted EPS was $2.34 versus $2.27.
2025 non-GAAP EPS guidance raised to $9.30 to $9.80 from $9.10 to $9.60; reported revenue guidance is now (5.5)% to (3.5)%.
The company repurchased $350 million of common stock in Q1 and had $549.3 million remaining on its $1.0 billion authorization as of March 29, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.